Investors

Over 120 LP’s in Canada do not have the licence or equipment available to meet their extraction needs.

As legalization takes hold, that need will continue to grow along with the demand for cannabis products and extracts on the global market for alternative medicine.

This is just the start of a highly diverse and successful industry that has just started to be recognized globally.

The company is committed to the research and development of cannabinoids, terpenes, density, potency, and aroma in cannabis and producing excellent quality cannabis and hemp services. Benefits of CannaPiece includes consistent and reliable source of products for processing, packaging and distribution, revenue and profit through the cannabis value chain, and access to some of the best growers and growing practices in the nation.

In addition, our facilities are also under expansion with the addition of 30,000 square feet under construction and at least 70,000 square feet to be added on by June 2021.

Our MGC business model is one of the most innovative, fastest and safest way to enter the highly-successful and fast growing craft cannabis industry.

This perfect time is now, and this is just the beginning. Let us help take you to where you want to be.

 
0

Medical Patients Registered in Canada by 2020

$ 0 B

Canadian Medical Market Size

$ 0 B

Potential Canadian Recreational sales in 2019

0 B

European medical and recreational markets expected growth by 2028

Recent Press Releases

CannaPiece Statement on COVID-19

Dear CannaPiece Team, Friends and Family, Nothing is more important to us at CannaPiece than the health and safety of our employees, customers, partners and